These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32949232)

  • 21. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
    Wang Y; Chen Q; Wang N; Chen H; Lyu Q; Kuang Y
    Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.
    Lambalk CB; Banga FR; Huirne JA; Toftager M; Pinborg A; Homburg R; van der Veen F; van Wely M
    Hum Reprod Update; 2017 Sep; 23(5):560-579. PubMed ID: 28903472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.
    Castillo JC; Haahr T; Martínez-Moya M; Humaidan P
    Ups J Med Sci; 2020 May; 125(2):131-137. PubMed ID: 32366146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-Freeze - a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation: a statistical analysis plan.
    Bell JL; Hardy P; Greenland M; Juszczak E; Cole C; Maheshwari A; Bhattacharya S; Linsell L
    Trials; 2020 Jun; 21(1):596. PubMed ID: 32605633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for the management of OHSS: Results from freezing-all cycles.
    Borges E; Braga DP; Setti AS; Vingris LS; Figueira RC; Iaconelli A
    JBRA Assist Reprod; 2016 Mar; 20(1):8-12. PubMed ID: 27203299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embryo freezing for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002806. PubMed ID: 17636707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fresh versus frozen-thawed blastocyst transfer in high responders.
    Kalem Z; Namli Kalem M; Ruso H; Bakirarar B; Gurgan T
    Ginekol Pol; 2018; 89(8):407-413. PubMed ID: 30215458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome.
    Zech J; Brandao A; Zech M; Lugger K; Neururer S; Ulmer H; Ruttmann-Ulmer E
    Reprod Biol; 2018 Mar; 18(1):46-52. PubMed ID: 29279182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.
    Seyam E; Hefzy E
    Gynecol Endocrinol; 2018 Jul; 34(7):616-622. PubMed ID: 29334275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freeze-all embryo strategy in poor ovarian responders undergoing ovarian stimulation for in vitro fertilization.
    Xue Y; Tong X; Zhu H; Li K; Zhang S
    Gynecol Endocrinol; 2018 Aug; 34(8):680-683. PubMed ID: 29465272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Freeze-all policy: is it time for that?
    Roque M
    J Assist Reprod Genet; 2015 Feb; 32(2):171-6. PubMed ID: 25428436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Freeze-all cycle for all normal responders?
    Roque M; Valle M; Guimarães F; Sampaio M; Geber S
    J Assist Reprod Genet; 2017 Feb; 34(2):179-185. PubMed ID: 27817036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.